News Focus
News Focus
icon url

k9painter

12/24/09 5:21 PM

#766 RE: PenelopePitstop #765

i totally agree. if we are back down to pinks it stops a lot of potential investors from taking a position.
icon url

k9painter

12/24/09 5:25 PM

#768 RE: PenelopePitstop #765

i would like to see the stock move up on its own merits. ir is fine but with fundamentals being in place, ir would be a much easier job. dont have to sell as hard if the co performs!!! jmho and is probably wrong!! MERRY CHRISTMAS!!!! thanks for all your time and effort on this board also!!
icon url

MattMan87

12/29/09 10:45 AM

#797 RE: PenelopePitstop #765

Today would be a great day to get a PR regarding any of the following, considering the spread at the moment. Would see a good gap in share price with PR imo :)

Here is what we are looking forward to (all from Stace, great DD) in addition to filing....

Just spoke to Jon on how the company (CLRA) is doing:

Clearant has signed an LOI (exclusive contract) with Regeneration Technologies (RTIX). The new organization will process allograft tissue using the patented Clearant Process. RTI will continue to develop new tissue technology and process tissue at its headquarters in Alachua.

Jon also said they have landed more direct distribution contracts and will file a PR/8K in the very near future along with the 10Q.

I asked about RTIX and CLRA merging and he said it is a distinct possibility.

Stace



One other item I forgot to mention is that it looks like he landed a requirement that all cancer treated patients MUST have the Clearant Process invoked. This could be a huge step in the right direction.

Currently, the absence of large, high quality cancer tissue and blood collections with clinical data is a major impediment to improving the care of cancer patients. There is compelling evidence that new methods for screening, diagnosis and evaluation of cancer can make a significant impact on cancer care in the immediate future. I do believe that Jon has been busy marketing their patented sterilization process to the Oncology folks.

Stace